Verla-Tebit E - Search Results

1

SULT1A1 genotype and susceptibility to colorectal cancer.

Lilla C, Risch A, Verla-Tebit E, Hoffmeister M, Brenner H, Chang-Claude J. Lilla C, et al. Among authors: verla tebit e. Int J Cancer. 2007 Jan 1;120(1):201-6. doi: 10.1002/ijc.22156. Int J Cancer. 2007. PMID: 17013894

2

Anthropometric factors and the risk of premenopausal breast cancer in Germany.

Verla-Tebit E, Chang-Claude J. Verla-Tebit E, et al. Eur J Cancer Prev. 2005 Aug;14(4):419-26. doi: 10.1097/00008469-200508000-00016. Eur J Cancer Prev. 2005. PMID: 16030434

3

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.

Verla-Tebit E, Wang-Gohrke S, Chang-Claude J. Verla-Tebit E, et al. Breast Cancer Res. 2005;7(4):R455-64. doi: 10.1186/bcr1027. Epub 2005 Apr 12. Breast Cancer Res. 2005. PMID: 15987450 Free PMC article.

4

Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.

Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J. Lilla C, et al. Among authors: verla tebit e. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):99-107. doi: 10.1158/1055-9965.EPI-05-0618. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434594

5

Cigarette smoking and colorectal cancer risk in Germany: a population-based case-control study.

Verla-Tebit E, Lilla C, Hoffmeister M, Brenner H, Chang-Claude J. Verla-Tebit E, et al. Int J Cancer. 2006 Aug 1;119(3):630-5. doi: 10.1002/ijc.21875. Int J Cancer. 2006. PMID: 16496385

6

Exposure to environmental tobacco smoke and the risk of colorectal cancer in a case-control study from Germany.

Verla-Tebit E, Lilla C, Hoffmeister M, Brenner H, Chang-Claude J. Verla-Tebit E, et al. Eur J Cancer Prev. 2009 Feb;18(1):9-12. doi: 10.1097/CEJ.0b013e3282f0c06c. Eur J Cancer Prev. 2009. PMID: 19077559

7

CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.

Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J. Piller R, et al. Among authors: verla tebit e. J Nutr. 2006 Jun;136(6):1596-603. doi: 10.1093/jn/136.6.1596. J Nutr. 2006. PMID: 16702327 Free article.

8

Regression of hepatocellular carcinoma after treatment of hepatitis C: a case report.

Verla-Tebit E, Rahma OE. Verla-Tebit E, et al. J Gastrointest Oncol. 2015 Jun;6(3):E52-4. doi: 10.3978/j.issn.2078-6891.2014.115. J Gastrointest Oncol. 2015. PMID: 26029467 Free PMC article.

9

Acquired inhibitors to factor VIII and fibrinogen in the setting of T-cell large granular lymphocyte leukemia: a case report and review of the literature.

Murphy PW, Brett LK, Verla-Tebit E, Macik BG, Loughran TP Jr. Murphy PW, et al. Among authors: verla tebit e. Blood Coagul Fibrinolysis. 2015 Mar;26(2):211-3. doi: 10.1097/MBC.0000000000000209. Blood Coagul Fibrinolysis. 2015. PMID: 25396761 Review.

10

Predictive value of immunization records and risk factors for immunization failure in internationally adopted children.

Verla-Tebit E, Zhu X, Holsinger E, Mandalakas AM. Verla-Tebit E, et al. Arch Pediatr Adolesc Med. 2009 May;163(5):473-9. doi: 10.1001/archpediatrics.2009.26. Arch Pediatr Adolesc Med. 2009. PMID: 19414695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters